Table 1 Summary of recommended tests for use with different sites of samples.
| Test | Sites FCU | Cervix | Urethra | Pharynx | Rectum | Vulvo‐ vaginal |
|---|---|---|---|---|---|---|
| NAAT | 1 | 1 | 1 | 3 | 3 | 3 |
| EIA | 4 | 2 | 2 | 5 | 5 | 5 |
| DFA | 2 | 2 | 2 | 2 | 2 | 5 |
| TC | 5 | 2 | 2 | 1 | 1 | 5 |
NAAT, nucleic acid amplification test; EIA, enzyme immunoassay; DFA, direct fluorescent antibody; TC, tissue culture.
1, test of choice; 2, acceptable, but not first choice; 3, not licensed, although encouraging work being performed; 4, only for use in asymptomatic males; 5, not recommended.
All recommendations are at grade B unless stated otherwise.